UK Private Acute Healthcare Market 2021: Growing Interest in Self-Pay Owing to Long NHS Waiting Lists for Diagnostic and Elective Procedures

DUBLIN, Dec. 13, 2021 /PRNewswire/ -- The "Private Acute Healthcare UK Market Report (7th Edition)" report has been added to ResearchAndMarkets.com's offering.

The seventh edition of the Private Acute Healthcare UK Market Report is vital reading for anyone involved in this highly competitive sector of the UK health economy, be they providers, investors or advisors to the sector.

The first edition to be published since the start of the Covid-19 pandemic, the new report shows the position of the market immediately before the pandemic, the impact of the pandemic, and the private healthcare sector's recovery as the economy has started to reopen.

This market, estimated to be worth £6.17 billion in 2019, contracted by around 30% during the pandemic, as independent hospitals made beds, theatres and clinicians available to the NHS 'at cost' and elective surgery all but stopped. The overseas market disappeared as travel restrictions were imposed.

However, the market revived strongly in late 2020 and then again following the 2021 lockdown. The number of people treated on private medical insurance has increased, as has the number of NHS-funded admissions as NHS managers have sought to reduce waiting lists.

There has also been growing interest in self-pay owing to long NHS waiting lists for diagnostic and elective procedures. Benefitting from London's reputation for medical excellence, the UK has also attracted patients from overseas as travel restrictions have eased.

Nevertheless, future profitability is hard to predict. Unknowns include the future patient mix and funding tariffs, together with the current economic uncertainties created by economic slowdown, inflation rises, supply shocks and staffing challenges. This important report provides a crucial update on the current position of the market and its key emerging trends.

What the report covers

• UK Hospitals & Clinics Overview
• Funding
• Market Structure
• PMI
• NHS Purchasing
• Self-pay
• NHS Private Patients
• Other Market Components
• Activity
• Specialists
• Political Environment & the NHS
• Regulation
• Futures
• Financial Appendix

Key Topics Covered:

1. MARKET
1.1 Scope and definition
1.2 Private acute medical care providers - market size
1.3 Private acute medical hospitals and clinics market
1.4 Private patients only (PPO) hospital market
1.5 NHS Private Patients
1.6 Other private acute medical care components
1.7 Specialists' private practice fee income
1.8 Funding by payor type - independent acute healthcare hospitals and clinics
1.9 Private acute medical care - market structure and activity overview
1.10 Activity - independent sector's patient admissions
1.11 Market structure of Private Patient Units and structural trends
1.12 Staffing - specialists
1.13 Performance measures

2. POLITICS AND REGULATION
2.1 Overview
2.2 Key impacts from government policy
2.2.1 NHS use of the independent sector
2.2.2 Patient choice and best provider
2.2.3 Independent sector NHS partnership opportunities
2.3 Historic government policy
2.3.1 Emergence and development of private acute medical care 1973-1997
2.3.2 Philosophical opposition to private healthcare under Labour 1997-2000
2.3.3 Engaging the independent sector to upscale NHS performance 2000-2010
2.3.4 The Coalition government - reforms in action, 2010-2015
2.3.5 Political environment for the NHS under Theresa May
2.3.6 Labour Party policy for the NHS in 2019
2.4 Regulation of the independent acute medical care sector
2.4.1 Overview
2.4.2 Regulation of quality standards by the Care Quality Commission
2.4.2.1 Scope of independent acute medical care regulation in England
2.4.2.2 Outside the scope of regulation
2.4.2.3 The essential standards in England
2.4.2.4 Care Quality Commission developments for independent acute hospitals and clinics
2.4.3 Covid impact
2.5 The quality agenda
2.6 Competition investigations

3. PAYORS
3.1 Private medical cover
3.2 NHS purchasing
3.3 Self-pay patients
3.4 Overseas

4. MAJOR PROVIDERS
4.1 Independent sector - market concentration and shares
4.2 Independent sector - provider type
4.3 New independent acute medical capacity and structural trends
4.4 NHS providers - private income market shares
4.5 Other acute markets

5. INVESTORS
5.1 Major investor review
5.1.1 Nordic Capital
5.1.2 Palatine Private Equity
5.1.3 TriSpan
5.1.4 H2 Equity Partners
5.1.5 Hospital Topco Ltd
5.1.6 Mediclinic International
5.1.7 HCA Healthcare Inc.
5.1.8 Bridgepoint Capital
5.1.9 Centene Corporation
5.1.10 NMC Health plc
5.1.11 Aurelius
5.1.12 Fidelity International
5.1.13 RCapital
5.1.14 BlueGem Capital Partners
5.1.15 Life Healthcare
5.1.16 China Resources Group & Macquarie Group
5.1.17 Apposite Capital
5.1.18 CBPE Capital
5.1.19 Schroders UK Public Private Trust
5.1.20 Investors in the fertility sector
5.2 Recent acquisitions in the sector

6. MARKET POTENTIAL

For more information about this report visit https://www.researchandmarkets.com/r/zdjazm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets